Cargando…

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort

INTRODUCTION: Epidemiological studies suggest that some antiretroviral drugs may contribute to increase cardiovascular risk in HIV-infected patients. However, data from Latin American countries are limited, as impact of HAART on cardiovascular risk remains understudied. In this context, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cecchini, Diego, Ines Mattioli, Maria, Cassetti, Julia, Chan, Debora, Cassetti, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P015
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224907/ https://www.ncbi.nlm.nih.gov/pubmed/25394054 http://dx.doi.org/10.7448/IAS.17.4.19547

Ejemplares similares

COVID-19, child inactivity and the introduction of an online exercise class
por: Davies, S., et al.
Publicado: (2022)

PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION
por: Rosenblum, J., et al.
Publicado: (2022)

PANDEMIA DE COVID-19 E MÍDIA: O TRABALHO DA ASSESSORIA DE COMUNICAÇÃO DE UM HOSPITAL DE DOENÇAS INFECCIOSAS
por: Sombra, Diego Pereira, et al.
Publicado: (2022)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

Pathogen identification in travelling patients with severe acute respiratory infections from the Middle East to the Philippines, 2014–2016
por: Morito, H.L.E., et al.
Publicado: (2019)

IMPACTO DAS ESTRATÉGIAS NÃO FARMACÊUTICAS SOBRE A EVOLUÇÃO DA COVID‐19 NO ESTADO DE SÃO ESTADO DE SÃO PAULO
por: Fortaleza, Cristiane Ravagnani, et al.
Publicado: (2021)

AVALIAÇÃO CLÍNICO-EPIDEMIOLÓGICA DA INFECÇÃO PELO SARS-COV-2 EM MORADORES DO MUNICÍPIO DE MARACANÃ, NO ESTADO DO PARÁ
por: de Lima, Aline Cecy Rocha, et al.
Publicado: (2022)

Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)
por: Tookey, Pat, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States
por: Peng, Siyang, et al.
Publicado: (2014)

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults
por: Gatell, Josép M, et al.
Publicado: (2014)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years
por: Gazzard, Brian, et al.
Publicado: (2014)

Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study
por: Baran, Robert, et al.
Publicado: (2014)

144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
por: Wolf, Eva, et al.
Publicado: (2014)

Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia
por: Gleason, Rudolph L., et al.
Publicado: (2015)

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients
por: Berno, Giulia, et al.
Publicado: (2014)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Burden of subclinical heart and lung disease detected on thoracic CT scans of HIV patients on HAART
por: Zona, Stefano, et al.
Publicado: (2014)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Transmitted drug resistance in women with intrapartum HIV-1 diagnosis: a pilot epidemiological survey in Buenos Aires, Argentina
por: Cecchini, Diego, et al.
Publicado: (2014)

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort
por: Di Biagio, Antonio, et al.
Publicado: (2014)

Potential drug–drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina
por: Cordova, Ezequiel, et al.
Publicado: (2014)

Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1(st) PI-Based Regimen
por: Cahn, Pedro, et al.
Publicado: (2011)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

Dual therapy with raltegravir plus a fixed dose combination of darunavir/ritonavir in people living with HIV in Argentina
por: Rombini, Fernanda, et al.
Publicado: (2020)

Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
por: Maggiolo, F, et al.
Publicado: (2012)

Resistance to HIV integrase strand transfer inhibitors in Argentina: first interim survey
por: Cecchini, Diego M., et al.
Publicado: (2019)

High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study
por: Estrada, V, et al.
Publicado: (2012)

O.1.3-2 Development and implementation of physical activity policies at national and subnational levels: a pilot study in Latin American countries
por: Grueso, Juliana Mejía, et al.
Publicado: (2023)

Mental health, coping, and social support among people living with HIV in the Americas: A comparative study between Argentina and the USA during the SARS-CoV-2 pandemic
por: Jones, Deborah L., et al.
Publicado: (2020)

Mental Health, Coping, and Social Support Among People Living with HIV in the Americas: A Comparative Study Between Argentina and the USA During the SARS-CoV-2 Pandemic
por: Jones, Deborah L., et al.
Publicado: (2021)

HIV test: which is your best? A National survey on testing preferences among MSM in Italy
por: Mattioli, Sandro, et al.
Publicado: (2014)

Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
por: Cooper, V, et al.
Publicado: (2010)

Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
por: Deng, Lisi, et al.
Publicado: (2020)

Status of coupling compensation for the LPv3 optics in 1995
por: Verdier, A
Publicado: (1995)

Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill
por: Perez-Valero, I, et al.
Publicado: (2010)

MEMRI study - feedback of MEMS dosing history improves adherence to long-term HAART: adherence is associated with incidence of ‘blips’ in viral load
por: White, D, et al.
Publicado: (2012)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America
por: Crabtree-Ramírez, Brenda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l0gvgg4195b5c41e3ni6pj32i2